US Stock MarketDetailed Quotes

GYRE Gyre Therapeutics

Watchlist
  • 11.720
  • -0.360-2.98%
Close Jul 3 13:00 ET
  • 11.610
  • -0.110-0.94%
Post 14:07 ET
1.00BMarket Cap-11423P/E (TTM)

Gyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-72.31%2.88M
142.50%25.89M
15.80%10.42M
-48.56%10.68M
9M
20.76M
Net income from continuing operations
135.59%9.94M
-2,081.46%-85.48M
-46.83%4.22M
-85.43%4.31M
--7.93M
--29.6M
Operating gains losses
-1,332.36%-4.23M
5,371.76%13.95M
8,986.21%343K
197.45%255K
--3.77K
---261.68K
Depreciation and amortization
48.60%425K
-1.33%1.11M
-41.53%286K
-41.45%1.13M
--489.17K
--1.93M
Deferred tax
4.57%-313K
-38.42%-1.16M
---328K
---838K
----
----
Other non cash items
-2,387.50%-183K
36,531.42%82.79M
3.80%8K
128.66%226K
--7.71K
--98.84K
Change In working capital
-146.31%-2.76M
195.65%7.46M
610.33%5.95M
-45.72%-7.8M
--838.2K
---5.35M
-Change in receivables
-99.97%1K
116.44%1.3M
904.73%3.92M
-304.83%-7.92M
---486.5K
---1.96M
-Change in inventory
-226.86%-666K
298.75%1.75M
29.42%525K
63.70%-879K
--405.65K
---2.42M
-Change in prepaid assets
-124.78%-1.52M
-108.43%-82K
47.55%-678K
191.26%973K
---1.29M
---1.07M
-Change in payables and accrued expense
-114.35%-445K
1,006.11%5.07M
40.26%3.1M
82.92%458K
--2.21M
--250.39K
-Change in other current liabilities
86.48%-123K
-34.03%-575K
---910K
---429K
----
----
-Change in other working capital
----
----
----
----
----
---157.36K
Cash from discontinued investing activities
Operating cash flow
-72.31%2.88M
142.50%25.89M
15.80%10.42M
-48.56%10.68M
--9M
--20.76M
Investing cash flow
Cash flow from continuing investing activities
5.60%-7.22M
-43.04%-19.76M
-144.94%-7.65M
-68.65%-13.81M
-3.12M
-8.19M
Net PPE purchase and sale
89.61%-181K
-57.53%-7.85M
-197.80%-1.74M
-352.63%-4.99M
---584.96K
---1.1M
Net intangibles purchase and sale
--0
-430.77%-69K
97.44%-65K
99.82%-13K
---2.54M
---7.33M
Net business purchase and sale
----
401.88%4.02M
----
---1.33M
----
----
Net investment purchase and sale
-20.51%-7.04M
-110.25%-15.74M
---5.84M
-3,221.97%-7.48M
----
--239.72K
Net other investing changes
----
---124K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
5.60%-7.22M
-43.04%-19.76M
-144.94%-7.65M
-68.65%-13.81M
---3.12M
---8.19M
Financing cash flow
Cash flow from continuing financing activities
658K
2.5M
0
0
-127.88K
-6.83M
Net issuance payments of debt
----
----
----
----
---114.19K
---6.7M
Net preferred stock issuance
----
--2.5M
----
--0
----
----
Cash dividends paid
----
----
----
----
--0
--0
Proceeds from stock option exercised by employees
--658K
----
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
--658K
--2.5M
--0
--0
---127.88K
---6.83M
Net cash flow
Beginning cash position
33.10%33.51M
-16.65%25.18M
-3.75%25.18M
48.42%30.2M
--26.16M
--20.35M
Current changes in cash
-232.83%-3.68M
375.17%8.63M
-51.80%2.77M
-154.65%-3.14M
--5.75M
--5.74M
Effect of exchange rate changes
-123.00%-46K
84.24%-298K
--200K
---1.89M
----
----
End cash Position
5.83%29.79M
33.10%33.51M
-11.78%28.14M
-3.50%25.18M
--31.9M
--26.09M
Free cash flow
-69.19%2.65M
204.74%17.31M
46.60%8.61M
-53.84%5.68M
--5.87M
--12.3M
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -72.31%2.88M142.50%25.89M15.80%10.42M-48.56%10.68M9M20.76M
Net income from continuing operations 135.59%9.94M-2,081.46%-85.48M-46.83%4.22M-85.43%4.31M--7.93M--29.6M
Operating gains losses -1,332.36%-4.23M5,371.76%13.95M8,986.21%343K197.45%255K--3.77K---261.68K
Depreciation and amortization 48.60%425K-1.33%1.11M-41.53%286K-41.45%1.13M--489.17K--1.93M
Deferred tax 4.57%-313K-38.42%-1.16M---328K---838K--------
Other non cash items -2,387.50%-183K36,531.42%82.79M3.80%8K128.66%226K--7.71K--98.84K
Change In working capital -146.31%-2.76M195.65%7.46M610.33%5.95M-45.72%-7.8M--838.2K---5.35M
-Change in receivables -99.97%1K116.44%1.3M904.73%3.92M-304.83%-7.92M---486.5K---1.96M
-Change in inventory -226.86%-666K298.75%1.75M29.42%525K63.70%-879K--405.65K---2.42M
-Change in prepaid assets -124.78%-1.52M-108.43%-82K47.55%-678K191.26%973K---1.29M---1.07M
-Change in payables and accrued expense -114.35%-445K1,006.11%5.07M40.26%3.1M82.92%458K--2.21M--250.39K
-Change in other current liabilities 86.48%-123K-34.03%-575K---910K---429K--------
-Change in other working capital -----------------------157.36K
Cash from discontinued investing activities
Operating cash flow -72.31%2.88M142.50%25.89M15.80%10.42M-48.56%10.68M--9M--20.76M
Investing cash flow
Cash flow from continuing investing activities 5.60%-7.22M-43.04%-19.76M-144.94%-7.65M-68.65%-13.81M-3.12M-8.19M
Net PPE purchase and sale 89.61%-181K-57.53%-7.85M-197.80%-1.74M-352.63%-4.99M---584.96K---1.1M
Net intangibles purchase and sale --0-430.77%-69K97.44%-65K99.82%-13K---2.54M---7.33M
Net business purchase and sale ----401.88%4.02M-------1.33M--------
Net investment purchase and sale -20.51%-7.04M-110.25%-15.74M---5.84M-3,221.97%-7.48M------239.72K
Net other investing changes -------124K----------------
Cash from discontinued investing activities
Investing cash flow 5.60%-7.22M-43.04%-19.76M-144.94%-7.65M-68.65%-13.81M---3.12M---8.19M
Financing cash flow
Cash flow from continuing financing activities 658K2.5M00-127.88K-6.83M
Net issuance payments of debt -------------------114.19K---6.7M
Net preferred stock issuance ------2.5M------0--------
Cash dividends paid ------------------0--0
Proceeds from stock option exercised by employees --658K------0------------
Cash from discontinued financing activities
Financing cash flow --658K--2.5M--0--0---127.88K---6.83M
Net cash flow
Beginning cash position 33.10%33.51M-16.65%25.18M-3.75%25.18M48.42%30.2M--26.16M--20.35M
Current changes in cash -232.83%-3.68M375.17%8.63M-51.80%2.77M-154.65%-3.14M--5.75M--5.74M
Effect of exchange rate changes -123.00%-46K84.24%-298K--200K---1.89M--------
End cash Position 5.83%29.79M33.10%33.51M-11.78%28.14M-3.50%25.18M--31.9M--26.09M
Free cash flow -69.19%2.65M204.74%17.31M46.60%8.61M-53.84%5.68M--5.87M--12.3M
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg